Forbion - Home

At Forbion Capital Partners we invest in Life Sciences and Biomedical Technology companies developing world-class drugs and technologies, with a clear focus on product development.

Learn more »

'For Biotech and Beyond'

09.01.2012 AM-Pharma Announces Appointment of Russell Greig as Chairman » 19.12.2011 arGEN-X is awarded €1.3 million IWT Grant to Advance Proprietary SIMPLE Antibody™ Platform for Addressing Challenging Disease Targets » 13.12.2011 Pieris Presents Preclinical Data for PRS-080 Hepcidin Antagonist AnticalinÒ Program at ASH Annual Meeting »

Pictures